Red Bank, NJ — (June 7, 2013) —The Board of Directors of Natcore Technology Inc. (TSX-V: NXT; NTCXF.PK) has appointed John Meekison, a Natcore Director, to the additional position of interim Chief Financial Officer until a suitable replacement can be found for Brian Zucker, who will remain with Natcore in another role. Mr. Meekison has stepped down from Natcore’s Audit Committee.
Mr. Meekison is a co-founder and Chief Financial Officer of Vancouver-based iCo Therapeutics Inc., a biopharmaceutical company developing clinical stage drugs for ophthalmic disease. He will continue his position as CFO of iCo.
# # # # #
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release
Comments are closed.